Abhisek Satapathy

Abhisek Satapathy

Auto-generated profile, based on publicly available information

Abhisek Satapathy

Pt J.N.M. Medical College, Railway Station Rd, Moudhapara, Raipur, 492001, C.G., India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Advances in Biomarker Sciences and Technology
Verified
Journal Article
Open access
TSTrilochan Satapathy
Trilochan Satapathy
NPNikita Patel
Nikita Patel
PSPoonam Sahu
Poonam Sahu
ASAbhisek Satapathy
Abhisek Satapathy

15 November 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
TSTrilochan Satapathy
Trilochan Satapathy
PSPoonam Sahu
Poonam Sahu
ASAbhisek Satapathy
Abhisek Satapathy
SBShiv Kumar Bhardwaj
Shiv Kumar Bhardwaj
ASAbinash Satapathy
Abinash Satapathy
MCManisha Chandrakar
Manisha Chandrakar
Nipah virus (NiV), a highly pathogenic member of the Henipavirus genus within the Paramyxoviridae family, continues to represent a critical zoonotic threat at the intersection of humans, animals, and the environment. First identified in Malaysia in 1998, NiV has since emerged as a paradigm of viral spillover driven by ecological disruption and anthropogenic activities. This review elucidates contemporary insights into the complex interplay governing NiV transmission dynamics, molecular neurotropism, and its potential to precipitate future pandemics. The spillover of NiV from its natural reservoir, Pteropus fruit bats, to intermediate hosts such as pigs, and ultimately to humans, is profoundly influenced by habitat fragmentation, agricultural intensification, and climate-induced alterations in bat foraging behavior. At the molecular level, NiV exhibits pronounced neurotropism and vasculotropism mediated through its interaction with ephrin-B2 and ephrin-B3 receptors, leading to widespread endothelial infection, microvascular damage, and neuronal dysfunction that culminate in fatal encephalitis. Moreover, the virus demonstrates immune evasion strategies that suppress interferon signaling, thereby facilitating systemic dissemination. Despite its high case fatality rate and recurrent outbreaks in South and Southeast Asia, the absence of licensed antiviral therapies or vaccines underscores the urgency of advancing translational research and cross-sectoral surveillance frameworks. The convergence of ecological perturbations, viral adaptability, and limited healthcare infrastructure in endemic regions amplifies the likelihood of future spillover and sustained human-to-human transmission. A unified One Health approach integrating virological, ecological, and epidemiological disciplines is imperative to mitigate NiV’s pandemic potential and to strengthen global preparedness against emerging zoonoses. Keywords: Neurotropism, Nipah virus (NiV), One Health, Pandemic preparedness, Spillover dynamics, Zoonotic transmission.

15 October 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
NPNikita Patel
Nikita Patel
TSTrilochan Satapathy
Trilochan Satapathy
PSPoonam Sahu
Poonam Sahu
ASAbhisek Satapathy
Abhisek Satapathy
SBShiv Kumar Bhardwaj
Shiv Kumar Bhardwaj
MCManisha Chandrakar
Manisha Chandrakar
One of the main characteristics of severe neurodegenerative disorders like amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington's disease (HD) is mitochondrial dysfunction. These disorders cause progressive neuronal degeneration due to abnormalities in mitochondrial energy metabolism, redox regulation, calcium homeostasis, and quality control pathways. Mechanistically, the key pathogenic causes are altered electron transport chain activity, dysregulated mitochondrial dynamics (fission and fusion), impaired mitophagy, and increased formation of reactive oxygen species (ROS). Furthermore, mutations in proteins such as PINK1, Parkin, SOD1, TDP-43, and huntingtin worsen mitochondrial instability and interfere with mitochondrial-nucleus communication.This review provides a comprehensive analysis of mitochondrial dysfunction from a mechanistic perspective, highlighting disease-specific pathways and molecular targets. We evaluate current and emerging pharmacological strategies, including mitochondria-targeted antioxidants, biogenesis activators, calcium modulators, and mitophagy enhancers. In addition, we discuss drug delivery innovations, such as mitochondrial-penetrating peptides and nanoparticle systems, as well as the clinical progress and limitations of mitochondrial therapies.By integrating insights from molecular biology, pharmacology, and translational neuroscience, this review outlines the therapeutic potential of targeting mitochondria and offers perspectives on future drug discovery aimed at mitigating neurodegeneration through mitochondrial repair and protection. Keywords: Mitochondrial dysfunction, neurodegenerative diseases, PINK1, Parkinson’s disease, Alzheimer’s disease, SIRT3

15 November 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
PSPoonam Sahu
Poonam Sahu
SBShiv Kumar Bhardwaj
Shiv Kumar Bhardwaj
ASAbinash Satapathy
Abinash Satapathy
ASAbhisek Satapathy
Abhisek Satapathy
AKArvind Kumar
Arvind Kumar
MCManisha Chandrakar
Manisha Chandrakar
Omega-3 fatty acids, including alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), are essential polyunsaturated fats known for their vital roles in cardiovascular, neurological, and inflammatory health. Growing awareness of their therapeutic benefits, coupled with sustainability concerns, has intensified research into their natural sources, biosynthesis, pharmacokinetics, and clinical applications. This review provides an integrative synthesis of recent advances in omega-3 fatty acid research, encompassing their sources, bioavailability, sustainability, mechanisms of action, and clinical relevance. Plant-based oils, marine fish, krill, and microalgae remain key natural sources, while innovations such as algal oils and genetically engineered crops present sustainable alternatives. The human conversion of ALA to EPA and DHA is inherently limited due to Δ6-desaturase and elongase enzyme constraints, with efficiency affected by genetic, hormonal, and dietary factors. Bioavailability is influenced by molecular form, with triglyceride, ethyl ester, and phospholipid structures displaying varying absorption and metabolic profiles. Mechanistically, omega-3 fatty acids regulate inflammation, maintain neuronal membrane integrity, and improve vascular function, with emerging evidence suggesting potential anti-cancer effects. Collectively, these insights underscore the significant preventive and therapeutic potential of omega-3 fatty acids and highlight the need for optimizing bioavailability, advancing sustainable production, and personalizing clinical applications to support future nutrition and healthcare strategies. Keywords: Omega-3 fatty acids, Eicosapentaenoic acid, Docosahexaenoic acid , Bioavailability, Sustainable nutrient sources, Clinical nutrition

1 January 2025 in Advances in Biomarker Sciences and Technology
Verified
Journal Article
Open access
PSPoonam Sahu
Poonam Sahu
TSTrilochan Satapathy
Trilochan Satapathy
ASAbhisek Satapathy
Abhisek Satapathy

26 December 2025 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
PSPoonam Sahu
Poonam Sahu
ASAbinash Satapathy
Abinash Satapathy
ASAbhisek Satapathy
Abhisek Satapathy
TSTrilochan Satapathy
Trilochan Satapathy